Skip to main content
. 2021 Jun 17;13(6):894. doi: 10.3390/pharmaceutics13060894

Figure 2.

Figure 2

Validation analysis of the removal of extraliposomal Cu(DDC)2 via surface area filtration. (a) Experimental procedure of testing consecutive filtration steps for the removal of extraliposomal Cu(DDC)2. The 1st + 2nd filtration was part of the liposome preparation process. The 3rd and 4th filtration were conducted to determine the limit of filtration steps until affecting liposomal stability. Aliquots were collected after each step to determine the D/L ratio and lipid amount. (b) The D/L ratio and lipid amount of non-PEGylated and PEGylated liposomes were analyzed after consecutive filtration steps and evaluated statistically via one-way ANOVA and Tukey’s multiple comparison test (* p = 0.0104). Data are expressed as the mean ± SD (n = 3–4).